James G. Herman MD FRCP(C)
Breast Cancer, Central Nervous System Cancer, Gastrointestinal Cancer, Urologic Cancer
MEDICAL DIRECTOR/PRESIDENT MMORA,PC/CHIEF RADIATION ONCOLOGY SPARROW CANCER CENTER
Join to View Full Profile
1215 E Michigan AveLansing, MI 48912
Phone+1 269-567-9835
Fax+1 269-567-9841
Dr. Herman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified medical and radiation oncologist,practising oncology at Sparrow Cancer Center.
My interests are breast cancer and gynaecologic cancers.
I also have an expertise in testicular cancer.
Education & Training
Hurley Medical Center/Michigan State UniversityInternship, Transitional Year, 1973 - 1974
University Saskatchewan Royal HospitalClass of 1973
Certifications & Licensure
MI State Medical License 1983 - 2026
American Board of Internal Medicine Medical Oncology
American Board of Radiology Therapeutic Radiology
Publications & Presentations
PubMed
- 9 citationsImplementation and Outcomes of a Molecular Tumor Board at Herbert-Herman Cancer Center, Sparrow HospitalHarsha Trivedi, Devansh Acharya, Ushasree Chamarthy, Joseph Meunier, Hussein Ali-Ahmad
Acta Medica Academica. 2019-06-26 - 37 citationsFeasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal modelsVineet K. Raghu, Wei Zhao, Jiantao Pu, Joseph K. Leader, Renwei Wang
Thorax. 2019-03-12 - 33 citationsFacile profiling of molecular heterogeneity by microfluidic digital meltChristine O’Keefe, Thomas R. Pisanic, Helena C. Zec, Michael J. Overman, James G. Herman
Science Advances. 2018-09-01
Grant Support
- Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignanciesUNIVERSITY OF PITTSBURGH AT PITTSBURGH2022–2027
- P1: Epigenetic Staging And Therapy For Lung CancersNational Cancer Institute2009–2012
- CHFR Methylation For Predicting Taxane Sensitivity In Lung And Esophageal CancerNational Cancer Institute2008–2011
- CHFR Methylation For Predicting Taxane Sensitivity In Lung And Esophageal CancerNational Cancer Institute2007
- Molecular Detection Of Breast CancerNational Cancer Institute2000–2002
Other Languages
- Ukrainian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
